December 11, 2018

BioMotiv Helps Fund Startup of Philadelphia Biotech Company

Cleveland-based drug development accelerator BioMotiv provided an initial startup investment to Aro Biotherapeutics, a new biotechnology company that holds an exclusive license for a next-generation protein drug platform.

Read More  >